ADRC News

Sterling Johnson, PhD, has been awarded a Vilas Distinguished Achievement Professorship, an appointment given to extraordinary members of the University of Wisconsin–Madison faculty.

This free community educational event offered news about cutting-edge research in Alzheimer's disease and provided information to help people improve brain health and live healthier lives.

The 'Dementia Matters' podcast turned five this month, marking nearly 150 episodes connecting scientists from UW–Madison and the national and international science community with thousands of listeners worldwide. The podcast is among the most highly-downloaded podcasts available, with listener numbers ranking it in the top twenty percent of all podcasts.

Fabu Carter, PhD, was recently presented with the 2022 Champion of Hope Award by NewBridge Madison.

Cynthia Carlsson, MD, MS, and Nathaniel Chin, MD, weigh in on the experimental drug lecanemab and share more about the AHEAD study happening at UW–Madison, one of 100 research sites in the world currently offering a clinical study of lecanemab.

Ozioma Okonkwo, PhD, and Beth Planalp, PhD, recently published an editorial in response to a new study indicating that walking between 3,800 and 9,800 steps daily may significantly reduce a person's risk of dementia.

Maria Mora Pinzon, MD, MS, a scientist in the Wisconsin Alzheimer’s Institute and a Wisconsin ADRC REC Scholar, received a K99 grant from the National Institute on Aging for her project that seeks to improve access to care for older adults, particularly those whose primary language is Spanish.

Manish Shah, MD, MPH, an expert in geriatric emergency medicine and an investigator in the Wisconsin Alzheimer’s Disease Research Center (ADRC), will be the new chair of the BerbeeWalsh Department of Emergency Medicine at the University of Wisconsin School of Medicine and Public Health (UWSMPH).

The Wisconsin Alzheimer’s Disease Research Center (ADRC) is accepting applications for its new Alzheimer’s Disease Developmental Projects awards, which offer up to $150,000 to support feasibility studies targeting research in Alzheimer’s disease and related dementias.

A multi-site research team from the University of California, Irvine, the University of Wisconsin–Madison and Wake Forest University has discovered that brain inflammation may link Alzheimer’s disease risk with sleep disturbance.